Executive record

Mark Strobeck, Ph.D.

Director at ROCKWELL MEDICAL, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:mark-strobeck-ph-dVersion: public-0As of: 2026-09-28

Not yet claimed13 published Claims4 sources
  • Director

Key Claims

Biography

Dr. Strobeck has served as Chairman of the Board since January 2025 and as a Board member since June 2023. He has served as President and Chief Executive Officer of Rockwell Medical, Inc. since July 2022, and has extensive biopharmaceutical industry experience including roles at Assertio Holdings, Zyla Life Sciences, and GlaxoSmithKline.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2025 to end not publishedExecutive title: Chairman of the Board of Directors · Organization not publishedWINT 10-K executive officers
  2. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not publishedRMTI DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. WINT 10-K executive officers

    sec filing · Source published: Apr 15, 2025 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at WINDTREE THERAPEUTICS INC /DE/ · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chairman of the Board of Directors · Claim reviewed: May 16, 2026
    • Other Company Role: Mark Strobeck, Ph.D. is also linked to Rockwell Medical, Inc. as President and Chief Executive Officer. · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  2. RMTI DEF 14A director slate

    sec filing · Source published: Apr 14, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Rockwell Medical, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  3. Open source

    sec proxy · Source published: Apr 14, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at ROCKWELL MEDICAL, INC. · Claim reviewed: May 16, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ROCKWELL MEDICAL, INC. · Claim reviewed: May 16, 2026